undamentalytics Newsletter

Koski Christine L: insider trades

Director at 2 companies we cover. 2 open-market purchases and 31 sales not made under a pre-set plan, reported from January 4, 2010 to November 13, 2019.

Would copying Koski Christine L’s purchases have beaten the S&P 500?

Too few purchases to judge. None of their purchases has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. After their sales, the shares moved +5.1% against the index over 12 months on average (a negative figure means selling was the right call); 47% trailed it. None of their purchases could be priced, so there is no copy portfolio.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Koski Christine L: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 30 +4.1% +3.6% 40% 10 −0.09 0.93 No reliable evidence
Sales, 12 months after the report 30 +5.1% +5.6% 47% 10 −0.23 0.82 No reliable evidence
Sales, 12 months after the trade 30 +4.2% +2.9% 47% 10 −0.44 0.67 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Helios Technologies, Inc. HLIO —030March 18, 2010November 13, 2019
Oragenics Inc OGEN —21January 4, 2010March 17, 2014

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
November 13, 2019November 11, 2019 HLIO Sale $587,732 −11.3%−8.9%−6.8%
September 13, 2019September 11, 2019 HLIO Sale $450,400 +1.1%−24.3%−25.1%
September 11, 2019September 10, 2019 HLIO Sale $446,000 −2.7%−24.5%−25.5%
June 11, 2019June 7, 2019 HLIO Sale $112,900 −3.4%−27.2%−26.1%
March 6, 2019March 1, 2019 HLIO Sale $248,500 −14.5%−25.6%−27.2%
September 7, 2018September 5, 2018 HLIO Sale $376,400 −18.5%−17.8%−15.1%
May 30, 2017May 25, 2017 HLIO Sale $243,846 +9.9%+2.7%+5.3%
April 4, 2017March 31, 2017 HLIO Sale $180,550 +15.3%+32.0%+32.8%
March 11, 2016March 9, 2016 HLIO Sale $499,815 −14.4%−11.7%−17.1%
March 16, 2015March 12, 2015 HLIO Sale $83,326 −4.8%−15.1%−13.8%
April 3, 2014April 1, 2014 HLIO Sale $221,920 −9.3%−13.9%−15.6%
March 17, 2014March 13, 2014 OGEN Sale $24,888 not yetnot yetnot yet
December 2, 2013November 27, 2013 HLIO Sale $1,261,216 +2.3%−16.5%−19.9%
November 26, 2013November 22, 2013 HLIO Sale $1,168,394 −4.9%−19.9%−14.3%
August 14, 2013August 12, 2013 HLIO Sale $111,876 +24.2%+8.8%+5.3%
June 21, 2013June 19, 2013 HLIO Sale $25,216 +12.5%+8.5%+11.4%
December 31, 2012December 27, 2012 HLIO Sale $930,632 +8.3%+18.5%+29.2%
December 27, 2012December 24, 2012 HLIO Sale $202,428 +18.1%+32.6%+28.6%
December 20, 2012December 18, 2012 HLIO Sale $697,302 +16.9%+28.5%+23.6%
December 10, 2012December 6, 2012 HLIO Sale $494,260 +13.6%+19.4%+25.7%
September 20, 2012September 19, 2012 HLIO Sale $300,206 −1.0%+17.9%+18.2%
March 21, 2012March 19, 2012 HLIO Sale $301,155 −12.9%+9.2%+0.5%
December 1, 2011November 30, 2011 HLIO Sale $125,000 +13.9%−2.7%−9.3%
March 24, 2011March 22, 2011 HLIO Sale $1,248,772 +11.0%−6.7%−6.1%
March 16, 2011March 14, 2011 HLIO Sale $294,533 +8.9%−2.1%−1.4%
December 7, 2010December 6, 2010 HLIO Sale $180,349 +20.3%+9.7%+9.4%
December 3, 2010December 3, 2010 HLIO Sale $46,976 +20.5%+9.4%+9.3%
December 3, 2010December 1, 2010 HLIO Sale $838,292 +20.5%+9.4%+14.2%
August 3, 2010July 30, 2010 OGEN Purchase $2,000,000 not yetnot yetnot yet
June 21, 2010June 18, 2010 HLIO Sale $242,682 +4.9%+61.1%+46.1%
May 27, 2010May 25, 2010 HLIO Sale $363,561 −3.4%+63.4%+55.1%
March 18, 2010March 16, 2010 HLIO Sale $137,914 +0.9%+37.8%+35.0%
January 4, 2010December 30, 2009 OGEN Purchase $2,250,000 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Koski Christine L traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.